Search Results for "Amgen Bergamo Portfolio"
Original Source: Amgen Inc.
Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of...
Matching Channels
EGF receptor Mab human rDNA Amgen
Novartis is the fourth largest pharmaceutical company in the world, based on annual sales, which are exceeded $36,000m in 2009. Founded in 1996, Novartis focuses of four main areas; pharmaceuticals,...
Matching News
Summary Website: Amgen Headquarters: Thousand Oaks CA, USA Ticker Symbol: AMGN (Nasdaq Stock Exchange) AMG (Frankfurt Stock Exchange) SEC Link: Amgen Subsidiaries: Abgenix Alantos Pharmaceuticals...
VistaGen Therapeutics (VSTA) has $36 M Strategic Financing Agreement with BERGAMO
For 72 M shares of restricted common stock VSTA signed a strategic financing agreement with the European subsidiary of Bergamo Acquisition Corp., a global diversified invest...
Amgen Spain: Success in Europe
In this episode of PharmaTelevision News Review, Fintan Walton talks with Jordi Marti, CEO at Amgen Spain. Filmed at Bio-Europe Spring 2010 in Barcelona, Spain, they discuss: • Why Amgen decided to...
[Atara Biotherapeutics] gets rights to six of [Amgen]'s drug candidates
As part of its spin-off from [Amgen Inc.], [Atara Biotherapeutics Inc.] has in-licensed several drug candidates. The new company--funded by Kleiner Perkins Caufield & Byers with Amgen holding a mino...
ROUNDUP: Amgen Lifts FY13 Adj. Earnings Outlook
THOUSAND OAKS (dpa-AFX) - Amgen Inc. (AMGN), said Thursday it plans to launch a portfolio of six new biosimilars beginning 2017 in a bid to tap a multi-billion dollar growth opportunity. The biote...
Amgen's New JV Fulfills Promise to Emphasize China
To date, Amgen, the US biotech drug company, has not had a major presence in China. In February of this year, Amgen said it would use a combination of partnerships and M&A to increase its particip...
Amgen is a top biotechnology company based in Thousand Oaks, CA, USA. The company was founded in 1980. Amgen discovers, develops, manufactures and delivers innovative human therapeutics. Amgen was one...
c-Met's highs and lows Amgen's c-Met experience Amgen Inc.'s rilotumumab improved survival in patients with gastric and gastroesophageal junction cancer whose tumors expressed high levels of c-Met, bu...
Matching PubMed Articles
Contact Allergy due to Lychee.
Abstract is missing (Letter).
ASXL1 mutations in primary and secondary myelofibrosis.
Bacterial Pericarditis due to Providencia stuartii: An Atypical Case of Relapsing Pericarditis.
